Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
Molecular Cancer Research : MCR|January 27, 2022
Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate CancerThomas Van den Broeck, Lisa Moris, Thomas Gevaert, et al.
European Urology|October 11, 2016
Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task ForceSilvia Villa, Friederike Kendel, Lionne Venderbos, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2016
Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer TrialMaria E Goossens, Maurice P Zeegers, Hendrik van Poppel, et al.
EJNMMI Research|August 7, 2013
18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot studyKimy M Emonds, Michel Koole, Cindy Casteels, et al.
European Urology|July 4, 2012
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomyGiacomo Novara, Vincenzo Ficarra, Simone Mocellin, et al.
BJU International|November 13, 2013
Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinibBenoit Beuselinck, Yann-Alexandre Vano, Stéphane Oudard, et al.
BMC Urology|March 23, 2012
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in BelgiumMaria E Goossens, Frank Buntinx, Steven Joniau, et al.
Journal of Personalized Medicine|January 22, 2024
Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U ConsortiumKatharina Beyer, Renée Leenen, Lionne D F Venderbos, et al.
European Urology Oncology|August 15, 2019
Validation of the Decipher Test for Predicting Distant Metastatic Recurrence in Men with High-risk Nonmetastatic Prostate Cancer 10 Years After SurgeryThomas Van den Broeck, Lisa Moris, Thomas Gevaert, et al.
European Urology Open Science|November 10, 2022
Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi StudyYvette Zimmerman, Mark Frydenberg, Hendrik van Poppel, et al.
Pageof 22